Ultran Tablets

Adult dose

Children aged 12 and older and adults: The dosage should be adjusted according to the severity of the patient's pain and the therapeutic response. The initial recommended dose is 2 tablets, followed by a minimum interval of 6 hours, ensuring that the total daily dosage does not exceed 8 tablets. Administer the lowest effective dose for the shortest duration possible. Avoid prolonged administration beyond what is necessary, and if prolonged treatment is required due to the nature and severity of the disease, regular monitoring should be conducted to confirm the continuation of this medication. Elderly: Administer the usual adult dose, but be cautious as the half-life of tramadol increased by 17% in patients over 75 years old; thus, intervals of at least 6 hours are recommended. Renal impairment: In patients with moderate renal impairment (creatinine clearance of 10-30 mL/min), extend the dosing interval to 12 hours. The use of this medication is not recommended in patients with severe renal impairment (creatinine clearance less than 10 mL/min). Tramadol is removed very slowly during hemodialysis, so there is no need to redose this medication to maintain analgesic effects after dialysis. Hepatic impairment: In patients with moderate hepatic impairment, carefully consider extending the dosing interval for administration. This medication is not to be administered in patients with severe hepatic impairment.

Child dose

Children aged 12 and older and adults: The dosage should be adjusted according to the severity of the patient's pain and the therapeutic response. The initial recommended dose is 2 tablets, followed by a minimum interval of 6 hours before subsequent doses.

This drug may cause liver damage in individuals who regularly consume more than three alcoholic drinks a day. It is essential to consult with a doctor or pharmacist. If you experience sudden rashes or blisters on the skin, or severe allergic reactions while taking this medication, stop taking it immediately and consult a healthcare professional. The ingredients in this medication may induce seizures, especially if taken in excess of the recommended dose or with certain antidepressants, narcotics, etc., which increases the risk of seizures. Patients with severe respiratory diseases may experience difficulty breathing while taking this medication, so it should be administered in an environment where healthcare professionals can monitor the patient. Taking this medication with alcohol or sedatives can cause severe drowsiness, respiratory depression, and coma, so concurrent use should be avoided. Caution is necessary for patients with head injuries or increased intracranial pressure, as this medication may burden the brain. This medication can cause both psychological and physical dependence, so dependence should be closely monitored during prolonged use. Patients with impaired liver function should consult a doctor before use, as some components of this medication are metabolized in the liver, which may pose a risk of liver damage. Patients with certain genetic metabolic capabilities may experience excessive accumulation of the active ingredient, leading to severe respiratory depression, so special attention is required. Children under 12 years of age and adolescents under 18 who have undergone tonsillectomy or adenoidectomy should not take this medication, and some adolescents are also advised to avoid it. This medication may cause sleep apnea and hypoxia; therefore, symptoms should be continuously monitored during use, and dosage adjustment or discontinuation may be considered as necessary. Hyponatremia may occur while taking this medication, so especially elderly patients or those at risk for hyponatremia should periodically check their serum sodium levels. Individuals with allergic reactions to any component of this medication, those with central nervous system drug overdose, severe respiratory depression, or head injuries should not take this medication. Women who are pregnant or may become pregnant should carefully consider the effects on the fetus before administration, and nursing mothers should avoid use for safety. Drowsiness or dizziness may occur while taking this medication, so caution is needed when driving or operating machinery. In cases of overdose, severe respiratory depression, seizures, and liver damage may occur, so do not exceed the recommended dosage, and if overdose is suspected, seek emergency medical assistance immediately. This medication interacts with various drugs; therefore, if you are taking other medications, be sure to inform and consult a doctor or pharmacist before use.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, mouth/eye mucosal pain, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis.

Mild side effects

• Loss of appetite
• insomnia
• depression
• dizziness
• headache
• drowsiness
• nausea
• vomiting
• constipation
• dry mouth

Store this medication in a sealed container to prevent air exposure, ideally in a temperature range of 1 to 30 degrees Celsius. Storing it this way helps maintain the drug's effectiveness over time.

Appearance

Pale yellow oblong film-coated tablets

Package unit

For domestic use: 30 tablets/bottle, 300 tablets/bottle For export: 100 tablets (10 tablets/PTP*10)